{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:08:45Z","timestamp":1783390125762,"version":"3.54.6"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T00:00:00Z","timestamp":1494374400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00482-017-0209-y","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T11:57:28Z","timestamp":1494417448000},"page":"200-230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Methodenreport der Leitlinie 2017 zum Fibromyalgiesyndrom","Methodology report of the 2017 guidelines on fibromyalgia syndrome"],"prefix":"10.1007","volume":"31","author":[{"given":"W.","family":"H\u00e4user","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nothacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,10]]},"reference":[{"key":"209_CR1","first-page":"742","volume":"152","author":"JN Ablin","year":"2013","unstructured":"Ablin JN, Amital H, Ehrenfeld M, Aloush V, Elkayam O, Langevitz P, Mevorach D, Mader R, Sachar T, Amital D, Buskila D, Israeli Rheumatology Association (2013) Guidelines for the diagnosis and treatment of the fibromyalgia syndrome. Harefuah 152:742\u2013747 (751, 750)","journal-title":"Harefuah"},{"key":"209_CR2","volume-title":"Erarbeitung von Leitlinien f\u00fcr Diagnostik und Therapie. Methodische Empfehlungen","author":"Arbeitsgemeinschaft wissenschaftlicher Fachgesellschaften AWMF","year":"2008","unstructured":"Arbeitsgemeinschaft wissenschaftlicher Fachgesellschaften AWMF (2008) Erarbeitung von Leitlinien f\u00fcr Diagnostik und Therapie. Methodische Empfehlungen. \n                        www.awmf.org\/fileadmin\/user_upload\/Leitlinien\/Werkzeuge\/...\/methoden.pdf\n                        \n                    . Zugegriffen: 20. Dez. 2008"},{"key":"209_CR3","first-page":"468","volume":"99","author":"Arbeitsgemeinschaft wissenschaftlicher Fachgesellschaften AWMF","year":"2006","unstructured":"Arbeitsgemeinschaft wissenschaftlicher Fachgesellschaften AWMF, \u00c4rztliches Zentrum f\u00fcr Qualit\u00e4t in der Medizin (\u00c4ZQ) (2006) Deutsches Instrument zur methodischen Leitlinienbewertung (DELBI). Z\u00a0Arztl Fortbild Qual Gesundhwes 99:468\u2013492","journal-title":"Z Arztl Fortbild Qual Gesundhwes"},{"key":"209_CR4","volume-title":"Erkl\u00e4rung von und Umgang mit Interessenkonflikten bei Leitlinienvorhaben","author":"Arbeitsgemeinschaft wissenschaftlicher Fachgesellschaften","year":"2016","unstructured":"Arbeitsgemeinschaft wissenschaftlicher Fachgesellschaften (2016) Erkl\u00e4rung von und Umgang mit Interessenkonflikten bei Leitlinienvorhaben. \n                        www.awmf.org\/leitlinien\/awmf-regelwerk\/ll-entwicklung\/awmf-regelwerk-01-planung-und-organisation\/po-interessenkonflikte\/interessenskonflikte.html\n                        \n                    . Zugegriffen: 2. Mai 2016"},{"key":"209_CR5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00482-008-0670-8","volume":"22","author":"K Bernardy","year":"2008","unstructured":"Bernardy K, Klose P, \u00dc\u00e7eyler N, Kopp I, H\u00e4user W (2008) Methodische Grundlagen der Leitlinienentwicklung (Methodenreport). Schmerz 22:244\u2013245","journal-title":"Schmerz"},{"key":"209_CR6","volume-title":"Programm f\u00fcr Nationale Versorgungsleitlinien \u2013 Methodenreport","year":"2008","unstructured":"Bundes\u00e4rztekammer, AWMF, Kassen\u00e4rztliche Bundesvereinigung (Hrsg) (2008) Programm f\u00fcr Nationale Versorgungsleitlinien \u2013 Methodenreport. \u00c4ZQ, Berlin"},{"issue":"9665","key":"209_CR7","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","volume":"373","author":"A Cipriani","year":"2009","unstructured":"Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373(9665):746\u2013758","journal-title":"Lancet"},{"key":"209_CR8","volume-title":"Statistical power analysis for the behavoral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavoral sciences. Lawrence Erlbaum Associates, Hillsdale"},{"key":"209_CR9","volume-title":"S3-Leitlinie\/Nationale VersorgungsLeitlinie Unipolare Depression \u2013 Langfassung, 2.\u00a0Auflage. Version 4","author":"DGPPN","year":"2015","unstructured":"DGPPN, B\u00c4K, KBV, AWMF, Akd\u00c4, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (2015) S3-Leitlinie\/Nationale VersorgungsLeitlinie Unipolare Depression \u2013 Langfassung, 2.\u00a0Auflage. Version 4. \n                        www.depression.versorgungsleitlinien.de\n                        \n                    . Zugegriffen: 20. Okt. 2015"},{"key":"209_CR10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/918216","volume":"18","author":"MA Fitzcharles","year":"2013","unstructured":"Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choini\u00e8re M, Ko G, Moulin DE, Panopalis P, Proulx J, Shir Y, National Fibromyalgia Guideline Advisory Panel (2013) 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag 18:119\u2013126","journal-title":"Pain Res Manag"},{"issue":"4","key":"209_CR11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00103-008-0514-9","volume":"51","author":"M H\u00e4rter","year":"2008","unstructured":"H\u00e4rter M, Klesse C, Bermejo I, Lelgemann M, Weinbrenner S, Ollenschl\u00e4ger G, Kopp I, Berger M (2008) Development of national guidelines for depression. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51(4):451\u2013457","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"26","key":"209_CR12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00482-012-1189-6","volume":"2012","author":"W H\u00e4user","year":"2012","unstructured":"H\u00e4user W, Wang H, Bernardy K, Kopp I (2012) Methodenreport zur Erstellung der Leitlinie. Schmerz 2012(26):232\u2013246","journal-title":"Schmerz"},{"key":"209_CR13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00482-014-1462-y","volume":"29","author":"W H\u00e4user","year":"2015","unstructured":"H\u00e4user W, Klose P, Welsch P, Petzke F, Nothacker M, Kopp I (2015) Methodology of the development of the updated LONTS guidelines for long-term administration of opioids in noncancer pain. Schmerz 29:8\u201334","journal-title":"Schmerz"},{"key":"209_CR14","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated march 2011)","year":"2011","unstructured":"Higgins JPT, Green S (Hrsg) (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated march 2011). \n                        www.cochrane-handbook.org\n                        \n                    . Zugegriffen: 20. Dez. 2016"},{"key":"209_CR15","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1055\/s-2004-813496","volume":"42","author":"J Hoffmann","year":"2004","unstructured":"Hoffmann J (2004) Methodische Basis f\u00fcr die Entwicklung der Konsensusempfehlungen. Z\u00a0Gastroenterol 42:984\u2013987","journal-title":"Z Gastroenterol"},{"key":"209_CR16","volume-title":"Fibromyalgiesyndrom: Definition, Pathophysiologie, Diagnostik und Therapie","author":"Leitlinienwatch","year":"2016","unstructured":"Leitlinienwatch (2016) Fibromyalgiesyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. \n                        https:\/\/www.leitlinienwatch.de\/fibromyalgiesyndrom-definition-pathophysiologie-diagnostik-und-therapie\/\n                        \n                    . Zugegriffen: 23. Mai 16"},{"key":"209_CR17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00482-011-1079-3","volume":"25","author":"U Marschall","year":"2011","unstructured":"Marschall U, Arnold B, H\u00e4user W (2011) Behandlung und Krankheitskosten des Fibromyalgiesyndroms in Deutschland. Eine Analyse der Daten der Barmer Ersatzkasse des Jahres 2008\u20132009. Schmerz 25:402\u2013410","journal-title":"Schmerz"},{"key":"209_CR18","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3899\/jrheum.090367","volume":"36","author":"P Mease","year":"2009","unstructured":"Mease P, Arnold LM, Choy EH, Clauw DJ, Crofford LJ, Glass JM, Martin SA, Morea J, Simon L, Strand CV, Williams DA, OMERACT Fibromyalgia Working Group (2009) Fibromyalgia syndrome module at OMERACT 9: domain construct. J\u00a0Rheumatol 36:2318\u20132329","journal-title":"J Rheumatol"},{"key":"209_CR19","volume-title":"Levels of evidence","author":"Oxford Centre for Evidence-Based Medicine","year":"2009","unstructured":"Oxford Centre for Evidence-Based Medicine (2009) Levels of evidence. ttp:\/\/\n                        www.cebm.net\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/\n                        \n                     (Erstellt: March 2009). Zugegriffen: 18. M\u00e4rz 2010"},{"key":"209_CR20","first-page":"A21","volume":"11","author":"M Schiltenwolf","year":"2017","unstructured":"Schiltenwolf M, Glanzmann P (2017) Haftung f\u00fcr Behandlungsfehler. Die Bedeutung des medizinischen Sachverst\u00e4ndigengutachtens. Dtsch Arztebl 11:A21\u2013A23","journal-title":"Dtsch Arztebl"},{"key":"209_CR21","volume-title":"Konsultationsfassung zur Interessenkonfliktregel: R\u00fcckmeldungen. Delegiertenkonferenz der AWMF 30.04.2016","author":"C Spies","year":"2016","unstructured":"Spies C, Kopp I (2016) Konsultationsfassung zur Interessenkonfliktregel: R\u00fcckmeldungen. Delegiertenkonferenz der AWMF 30.04.2016. \n                        http:\/\/www.awmf.org\/fileadmin\/user_upload\/Die_AWMF\/Delegiertenkonferenz\/DK-2016-04\/DK-2016-04_TOP10_Kopp.pdf\n                        \n                    . Zugegriffen: 30. Juni 2016"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00482-017-0209-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-017-0209-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-017-0209-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T09:57:37Z","timestamp":1496224657000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00482-017-0209-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,10]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["209"],"URL":"https:\/\/doi.org\/10.1007\/s00482-017-0209-y","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,10]]}}}